홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-(3-Chlorophenyl)piperazine dihydrochloride → 1-(3-Chlorophenyl)-4-[2-(isochroman-1-yl)ethyl]piperazine dihydrochloride

HRID 1417796
인쇄

반응식

HRID 1417796 반응식
[ClH:1].Cl.[Cl:3][C:4]1[CH:5]=[C:6]([N:10]2[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]2)[CH:7]=[CH:8][CH:9]=1.O.Cl.Cl.[CH:19]1([CH2:29][CH2:30]N2CCN(C3C=CC=CC=3OC)CC2)[C:28]2[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=2)[CH2:22][CH2:21][O:20]1>>[ClH:3].[ClH:1].[Cl:3][C:4]1[CH:5]=[C:6]([N:10]2[CH2:15][CH2:14][N:13]([CH2:30][CH2:29][CH:19]3[C:28]4[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=4)[CH2:22][CH2:21][O:20]3)[CH2:12][CH2:11]2)[CH:7]=[CH:8][CH:9]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 119574871-(3-Chlorophenyl)piperazine dihydrochlorideHCID 232889511-[2-(Isochroman-1-yl)ethyl]-4-(2-methoxyphenyl)piperazine dihydrochloride monohydrate2회

생성물 1

HCID 232887801-(3-Chlorophenyl)-4-[2-(isochroman-1-yl)ethyl]piperazine dihydrochloride

실험 절차

Following the general procedure of EXAMPLE 1 and making non-critical variations but using 1-(3-chlorophenyl)piperazine dihydrochloride (XI, 0.5169 g (1.92 mmol) in place of 1-(2-chlorophenyl)piperazine dihydrochloride (XI), the title compound is obtained, mp 176.75°-179°; MS (m/z) 356; IR (mineral oil) 2269, 2295, 2166, 2130, 2200 and 1449 cm-1.

출처 및 근거

ORD 기록
ord-2ef37158bc654cd2b5720f88ca6a23ef
출처 데이터셋
uspto-grants-1999_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05877317

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트